TY - JOUR
T1 - CMR First-Pass Perfusion for Suspected Inducible Myocardial Ischemia
AU - Hendel, Robert C.
AU - Friedrich, Matthias G.
AU - Schulz-Menger, Jeanette
AU - Zemmrich, Claudia
AU - Bengel, Frank
AU - Berman, Daniel S.
AU - Camici, Paolo G.
AU - Flamm, Scott D.
AU - Le Guludec, Dominique
AU - Kim, Raymond
AU - Lombardi, Massimo
AU - Mahmarian, John
AU - Sechtem, Udo
AU - Nagel, Eike
N1 - Funding Information:
This paper was funded by an unrestricted grant by Bayer Pharma AG. Drs. Hendel, Schulz-Menger, Zemmrich, and Nagel have received consultancy fees, attended advisory boards, and have held lectures for a number of pharmaceutical companies including Bayer HealthCare. Dr. Friedrich is a board member, advisor, and shareholder of and has received consultancy fees from Circle Cardiovascular Imaging Inc., a company that develops software for CMR image evaluation. Dr. Flamm has served as a consultant to Bayer HealthCare. Dr. Mahmarian has served on the Speakers Bureau of and as a consultant for Astellas. Dr. Nagel has received grant support from Siemens Healthcare, Bayer HealthCare, TomTec, CVI42, MEDIS, and Philips Healthcare.
Publisher Copyright:
© 2016 American College of Cardiology Foundation
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Cardiovascular magnetic resonance (CMR) has evolved from a pioneering research tool to an established noninvasive imaging method for detecting inducible myocardial perfusion deficits. In this consensus document, experts of different imaging techniques summarize the existing body of evidence regarding CMR perfusion as a viable complement to other established noninvasive tools for the assessment of perfusion and discuss the advantages and pitfalls of the technique. A rapid, standardized CMR perfusion protocol is described, which is safe, clinically feasible, and cost-effective for centers with contemporary magnetic resonance equipment. CMR perfusion can be recommended as a routine diagnostic tool to identify inducible myocardial ischemia.
AB - Cardiovascular magnetic resonance (CMR) has evolved from a pioneering research tool to an established noninvasive imaging method for detecting inducible myocardial perfusion deficits. In this consensus document, experts of different imaging techniques summarize the existing body of evidence regarding CMR perfusion as a viable complement to other established noninvasive tools for the assessment of perfusion and discuss the advantages and pitfalls of the technique. A rapid, standardized CMR perfusion protocol is described, which is safe, clinically feasible, and cost-effective for centers with contemporary magnetic resonance equipment. CMR perfusion can be recommended as a routine diagnostic tool to identify inducible myocardial ischemia.
KW - cardiac MRI
KW - diagnosis
KW - ischemic heart disease
UR - http://www.scopus.com/inward/record.url?scp=84994477642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84994477642&partnerID=8YFLogxK
U2 - 10.1016/j.jcmg.2016.09.010
DO - 10.1016/j.jcmg.2016.09.010
M3 - Review article
C2 - 27832901
AN - SCOPUS:84994477642
VL - 9
SP - 1338
EP - 1348
JO - JACC: Cardiovascular Imaging
JF - JACC: Cardiovascular Imaging
SN - 1936-878X
IS - 11
ER -